B2M and sarcopenia: These consistent experimental and clinical findings support the detrimental impact of B2M on muscle homeostasis, suggesting that B2M may be a therapeutic target for sarcopenia and raising the possibility that measuring serum B2M levels could offer additional insights for evaluating muscle health in old age.